OPKO Health Shares Outstanding 2010-2024 | OPK

OPKO Health shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
OPKO Health Annual Shares Outstanding
(Millions of Shares)
2023 752
2022 719
2021 648
2020 641
2019 595
2018 563
2017 559
2016 556
2015 488
2014 422
2013 355
2012 296
2011 281
2010 255
2009 233
OPKO Health Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 707
2023-12-31 752
2023-09-30 752
2023-06-30 752
2023-03-31 752
2022-12-31 719
2022-09-30 750
2022-06-30 713
2022-03-31 660
2021-12-31 648
2021-09-30 652
2021-06-30 647
2021-03-31 641
2020-12-31 641
2020-09-30 641
2020-06-30 641
2020-03-31 641
2019-12-31 595
2019-09-30 586
2019-06-30 586
2019-03-31 586
2018-12-31 563
2018-09-30 560
2018-06-30 560
2018-03-31 559
2017-12-31 559
2017-09-30 559
2017-06-30 564
2017-03-31 558
2016-12-31 556
2016-09-30 552
2016-06-30 557
2016-03-31 546
2015-12-31 488
2015-09-30 516
2015-06-30 462
2015-03-31 446
2014-12-31 422
2014-09-30 428
2014-06-30 413
2014-03-31 413
2013-12-31 355
2013-09-30 361
2013-06-30 337
2013-03-31 313
2012-12-31 296
2012-09-30 298
2012-06-30 298
2012-03-31 298
2011-12-31 281
2011-09-30 286
2011-06-30 285
2011-03-31 261
2010-12-31 255
2010-09-30 255
2010-06-30 255
2010-03-31 254
2009-12-31 233
2009-09-30 253
2009-06-30 226
2009-03-31 200
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.871B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
Edwards Lifesciences (EW) United States $52.601B 34.23
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Fresenius Medical Care AG KGaA (FMS) Germany $12.100B 14.12
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.50
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.54
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
Pacific Biosciences Of California (PACB) United States $0.479B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00